The LG 8MP Clinical Monitor 27HJ712CS-W is a 27-inch display that offers outstanding picture quality while boasting an impressive 178 degree wide viewing angle thanks to LG's In-plane switching technology.
This 4K monitor delivers 3840x2160 pixels, and aids in discerning minute details in analysis compared to dull, blurred regions in conventional monitors.
The LG clinical review monitor is compliant with DICOM Part 14, ensuring the most accurate and consistent shading in grayscale imagery.
Additionally, the color gamut covers over 99% of the sRGB color space for the most vibrant depiction of color without shift. Other features include low input lag, quick response times, and a dynamic sync mode that allows the monitor to receive signals quickly and display images without distortion.
Stephen Hu, head of commercial monitors for LG Electronics USA Business Solutions, said, "As a worldwide leader in the premium display industry, we are confident that LG medical imaging devices like our clinical and surgical monitors will help medical professionals improve the accuracy, quality, and efficiency of their procedures."
Brightness stabilization is an essential feature of the LG clinical monitor.
The backlit brightness stability sensor auto adjusts for variations caused by aging images, certifying consistent and reliable images throughout usage.
Lastly, the Flicker Safe and Reader Modes ensure surgeons work comfortably by lessening eye fatigue through the elimination of on-screen flickers and harmful blue light.
Ampronix is a distributor of the medical industry's top brands, as well as a world-class manufacturer of innovative technology.
Merck announces Phase 3 trials for once-monthly oral HIV prevention pill MK-8527
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
Estrella Immunopharma initiates second cohort in EB103 trial for advanced B-cell lymphomas
bioMérieux receives CE-marking for LUMED APSS to support antimicrobial stewardship in Europe
Merck reports positive Phase 3 Data on HIV treatment DOR/ISL
QOL Medical's Sucraid shows 81% effectiveness in Congenital Sucrase-Isomaltase Deficiency
Qlucore launches first CE-marked diagnostic test for paediatric leukaemia
Bruker demonstrates advancements in 4D-Proteomics at US HUPO
Mitem Pharma acquires Flisint rights from Sanofi to address rare infectious disease
Audientes partners with Audivista to expand hearing solutions in Middle East and North Africa
Benuvia Operations signs licensing deal with Avernus Pharma
Benuvia Operations signs licensing and supply agreements with Medra Brasil Medicamentos
Castle Biosciences to present data on Melanoma tests at ASDP Annual Meeting
Alchemy partners with PatchRx to improve HIV medication adherence